TY - JOUR
T1 - Demographic and clinical characteristics of chikungunya patients from six Colombian cities, 2014–2015
AU - Rueda, Juan C.
AU - Santos, Ana M.
AU - Angarita, Jose Ignacio
AU - Giraldo, Rodrigo B.
AU - Saldarriaga, Eugenia Lucia
AU - Ballesteros Muñoz, Jesús Giovanny
AU - Forero, Elías
AU - Valencia, Hugo
AU - Somoza, Francisco
AU - Martin-Arsanios, Daniel
AU - Quintero, Elias Josué
AU - Reyes-Martinez, Viviana
AU - Padilla, Diana
AU - Cuervo, Francy M.
AU - Peláez-Ballestas, Ingris
AU - Cardiel, Mario H.
AU - Pavía, Paula X.
AU - Londono, John
N1 - Publisher Copyright:
© 2019, © 2019 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group, on behalf of Shanghai Shangyixun Cultural Communication Co., Ltd.
PY - 2019/1/1
Y1 - 2019/1/1
N2 - In 2014, the chikungunya virus reached Colombia for the first time, resulting in a nationwide epidemic. The objective of this study was to describe the demographics and clinical characteristics of suspected chikungunya cases. Chikungunya infection was confirmed by enzyme-linked immunosorbent assay and 548 patients where included in the study. Of these patients, 295 were positive for antibodies against chikungunya (53.8%), and 27.6% (151/295) were symptomatic for chikungunya infection, with a symptomatic:asymptomatic ratio of 1.04:1. Factors associated with infection included low income and low socio-economic strata (odds ratio [OR]: 1.8; 95% confidence interval [CI]: 1.0–3.2, p = 0.003 and OR: 2.1; CI: 1.3–3.4, p = 0.002, respectively). Confirmed symptomatic cases were associated with symmetric arthritis (OR: 11.7; CI: 6.0–23.0, p < 0.001) of ankles (OR: 8.5; CI: 3.5–20.9, p < 0.001), hands (OR: 8.5; CI: 3.5–20.9, p < 0.001), feet (OR: 6.5; CI: 2.8–15.3, p < 0.001), and wrists (OR: 17.3; CI: 2.3–130.5, p < 0.001). Our study showed that poverty is associated with chikungunya infection. Public health strategies to prevent and control chikungunya should focus on poorer communities that are more vulnerable to infection. The rate of asymptomatic infections among confirmed cases was 48.8%. However, those with symptoms displayed a characteristic rheumatic clinical picture, which could help differentiate chikungunya infection from other endemic viral diseases.
AB - In 2014, the chikungunya virus reached Colombia for the first time, resulting in a nationwide epidemic. The objective of this study was to describe the demographics and clinical characteristics of suspected chikungunya cases. Chikungunya infection was confirmed by enzyme-linked immunosorbent assay and 548 patients where included in the study. Of these patients, 295 were positive for antibodies against chikungunya (53.8%), and 27.6% (151/295) were symptomatic for chikungunya infection, with a symptomatic:asymptomatic ratio of 1.04:1. Factors associated with infection included low income and low socio-economic strata (odds ratio [OR]: 1.8; 95% confidence interval [CI]: 1.0–3.2, p = 0.003 and OR: 2.1; CI: 1.3–3.4, p = 0.002, respectively). Confirmed symptomatic cases were associated with symmetric arthritis (OR: 11.7; CI: 6.0–23.0, p < 0.001) of ankles (OR: 8.5; CI: 3.5–20.9, p < 0.001), hands (OR: 8.5; CI: 3.5–20.9, p < 0.001), feet (OR: 6.5; CI: 2.8–15.3, p < 0.001), and wrists (OR: 17.3; CI: 2.3–130.5, p < 0.001). Our study showed that poverty is associated with chikungunya infection. Public health strategies to prevent and control chikungunya should focus on poorer communities that are more vulnerable to infection. The rate of asymptomatic infections among confirmed cases was 48.8%. However, those with symptoms displayed a characteristic rheumatic clinical picture, which could help differentiate chikungunya infection from other endemic viral diseases.
KW - Arbovirus
KW - Chikungunya virus
KW - Colombia
KW - Epidemic
KW - South America
UR - http://www.scopus.com/inward/record.url?scp=85073603715&partnerID=8YFLogxK
U2 - 10.1080/22221751.2019.1678366
DO - 10.1080/22221751.2019.1678366
M3 - Artículo
C2 - 31631794
AN - SCOPUS:85073603715
SN - 2222-1751
VL - 8
SP - 1490
EP - 1500
JO - Emerging Microbes and Infections
JF - Emerging Microbes and Infections
IS - 1
ER -